Market
BSE Prices delayed by 5 minutes... << Prices as on Oct 16, 2026 >>  ABB India  6816 [ -0.13% ] ACC  1186.95 [ 4.31% ] Ambuja Cements  362.9 [ 3.98% ] Asian Paints  2333 [ -1.00% ] Axis Bank  1286.45 [ -0.16% ] Bajaj Auto  10417 [ 0.52% ] Bank of Baroda  230 [ 0.83% ] Bharti Airtel  1905 [ 2.86% ] Bharat Heavy  434.1 [ -0.14% ] Bharat Petroleum  294 [ 0.15% ] Britannia Industries  4780 [ -2.32% ] Cipla  1325 [ -0.65% ] Coal India  416.9 [ -0.50% ] Colgate Palm  1772.55 [ -0.53% ] Dabur India  386 [ 0.26% ] DLF  674 [ 0.66% ] Dr. Reddy's Lab.  1231.85 [ 0.91% ] GAIL (India)  168.25 [ -0.27% ] Grasim Industries  2921 [ 0.62% ] HCL Technologies  1378 [ 1.08% ] HDFC Bank  728.1 [ -0.06% ] Hero MotoCorp  5230 [ 0.57% ] Hindustan Unilever  1898 [ 0.20% ] Hindalco Industries  910 [ 1.79% ] ICICI Bank  1396.8 [ 0.13% ] Indian Hotels Co.  772 [ 4.32% ] IndusInd Bank  874 [ -1.24% ] Infosys  1161.6 [ 4.55% ] ITC  263 [ -0.66% ] Jindal Steel  1040.4 [ 1.01% ] Kotak Mahindra Bank  446 [ -0.63% ] L&T  3632 [ -0.66% ] Lupin  1955.8 [ -0.17% ] Mahi. & Mahi  2920 [ 2.38% ] Maruti Suzuki India  11482 [ 0.50% ] MTNL  23.53 [ -0.34% ] Nestle India  1265 [ -1.17% ] NIIT  85.39 [ -2.03% ] NMDC  71.7 [ 1.10% ] NTPC  316.5 [ 0.76% ] ONGC  222.2 [ -1.20% ] Punj. NationlBak  116.1 [ 0.78% ] Power Grid Corpn.  250.95 [ 0.38% ] Reliance Industries  1210 [ -1.09% ] SBI  961.7 [ 0.02% ] Vedanta  246.5 [ 0.16% ] Shipping Corpn.  284.85 [ 0.26% ] Sun Pharmaceutical  1760 [ -0.03% ] Tata Chemicals  632.4 [ 0.72% ] Tata Consumer  977.2 [ -1.70% ] Tata Motors Passenge  286.9 [ 0.02% ] Tata Steel  175.6 [ -0.48% ] Tata Power Co.  353.45 [ 1.19% ] Tata Consult. Serv.  2463 [ 4.61% ] Tech Mahindra  1788 [ 8.45% ] UltraTech Cement  10928 [ 0.58% ] United Spirits  1376.1 [ -0.71% ] Wipro  184.4 [ 6.16% ] Zee Entertainment  72.01 [ -1.02% ] 
OneSource Specialty Pharma Ltd. Auditor Report
Search Company 
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 16143.78 Cr. P/BV 2.76 Book Value (Rs.) 510.69
52 Week High/Low (Rs.) 1925/1057 FV/ML 1/1 P/E(X) 0.00
Bookclosure EPS (Rs.) 0.00 Div Yield (%) 0.00
Year End :2026-03 

We have audited the accompanying standalone financial
statements of OneSource Specialty Pharma Limited (the
“Company”), which comprise the Standalone Balance Sheet
as at 31 March 2026, and the Standalone Statement of Profit
and Loss (including Other Comprehensive Income), the
Standalone Statement of Cash Flows and the Standalone
Statement of Changes in Equity for the year ended on that
date, and notes to the standalone financial statements,
including a summary of material accounting policies and
other explanatory information.

In our opinion and to the best of our information and according
to the explanations given to us, the aforesaid standalone
financial statements give the information required by the
Companies Act, 2013 (“the Act”) in the manner so required
and give a true and fair view in conformity with the Indian
Accounting Standards prescribed under Section 133 of the
Act, (“Ind AS”) and other accounting principles generally
accepted in India, of the state of affairs of the Company
as at 31 March 2026, and its profit, total comprehensive
income, its cash flows and the changes in equity for the year
ended on that date.

Basis for Opinion

We conducted our audit of the standalone financial
statements in accordance with the Standards on Auditing
(“SAs”) specified under Section 143(10) of the Act. Our
responsibilities under those Standards are further described
in the
Auditor’s Responsibility for the Audit of the Standalone
Financial Statements
section of our report. We are
independent of the Company in accordance with the Code
of Ethics issued by the Institute of Chartered Accountants
of India (“ICAI”) together with the ethical requirements
that are relevant to our audit of the standalone financial
statements under the provisions of the Act and the Rules
made thereunder, and we have fulfilled our other ethical
responsibilities in accordance with these requirements and
the ICAI’s Code of Ethics. We believe that the audit evidence
obtained by us is sufficient and appropriate to provide a basis
for our audit opinion on the standalone financial statements.

Key Audit Matters

Key audit matters are those matters that, in our professional
judgment, were of most significance in our audit of the
standalone financial statements of the current year.
These matters were addressed in the context of our audit
of the standalone financial statements as a whole, and
in forming our opinion thereon, and we do not provide a
separate opinion on these matters. We have determined the
matters described below to be the key audit matters to be
communicated in our report.

Sl.

No.

Key Audit Matters

Auditor’s responses

1

Impairment of Goodwill and related Cash
Generating Unit

(Refer note 4D and 4G of the standalone financial
statements)

The Management of the Company has assessed the
annual impairment of Goodwill recognised pursuant to
the scheme of arrangement and related assets of Cash
Generating Unit (CGU) which requires a comparison of
estimated recoverable value of the CGU to the carrying
value of the assets in the CGU.

The Management has arrived at recoverable value
based on value in use derived from discounted forecast
cash flow models involving external specialist.

We have considered this to be a key audit matter
considering the significance of the balance and
the value in use model uses several assumptions,
including estimates of future sales growth, operating
costs, terminal growth rates and weighted average
cost of capital.

Principal audit procedures performed included the following:

• We obtained an understanding of the Management’s
process for allocation of goodwill to a CGU and impairment
assessment of CGU.

• Evaluated the design and implementation of the relevant
controls and tested the operating effectiveness of controls
around the impairment assessment.

• We inquired with Management to understand the factors
considered when performing the impairment assessment
including the rationale for the events and circumstances
considered based on strategic plans of the entity (business
revenue projections), consideration of economic and
industry matters and the factors considered regarding the
overall value in use conclusion.

• Evaluated the competence of the Management’s expert
and the key assumptions considered in the management’s
estimates of future cash flows.

Sl.

No.

Key Audit Matters

Auditor’s responses

•

Evaluated the methodologies, terminal growth rate, the
discount rate applied, which included benchmarking the
weighted average cost of capital with sector averages
for the relevant markets in which the CGU operates and
considering Company specific factors and other key
assumptions considered in the calculations.

•

Performed sensitivity analysis on the key assumptions
within the forecast cash flows and focused our attention
on those assumptions we considered most sensitive to
the changes; such as revenue growth during the forecast
period, the terminal growth rate and the discount rate
applied to the future cash flows.

•

Performed the retrospective review of the projections.

•

We tested Management’s working of the extent to which
a change in these assumptions, both individually or in
aggregate, would result in impairment, and considered the
likelihood of such events occurring.

•

We tested the arithmetical accuracy of the computations.

•

We assessed the accounting principles applied by the
Company and adequacy and accuracy of disclosures
in accordance with the Indian Accounting Standards,
applicable regulatory financial reporting framework and
other accounting principles generally accepted in India.

2

Revenue recognition

Principal audit procedures performed included the following:

(Refer note 2.3 and note 20 of the standalone financial

•

We evaluated the design of internal controls over

statements)

recognition of revenue upon completion of performance

The Company’s revenue mainly arose from contract

obligations and in the appropriate period in accordance

development, manufacturing services and sale of

with the Company’s accounting policy.

pharmaceutical products. The Company recognises
revenue based on the terms and conditions of
transactions, which vary with different customers.
The Company recognises revenues upon completion

•

On a sample basis, we tested the operating effectiveness
of the internal controls relating to the determination of
point of time at which the performance obligations are

of performance obligations.

completed and transfer of control of the goods occurs.

For revenue recognised around balance sheet date, it

•

We tested the relevant information technology systems

is essential to ensure whether the transfer of control

used in recording the revenue including the Company’s

of the goods or completion of performance obligations
for services rendered by the Company to the customer
occurs before the balance sheet date.

system generated reports, based on which selection of
samples was undertaken.

Considering that there are significant volume of
revenue recognised close to the year end, involving
material amounts and such revenue recognition is
subject to transfer of control to customers before the
balance sheet date, we consider the risk of revenue

•

On sample basis, we performed test of details of revenues
recognised through following procedures:

- Analysed the terms and conditions of the underlying
contract with the customers; and

from operations being recognised prior to transfer of

- Verified the evidence for the transfer of control of the

control to customer to be a key audit matter.

goods/services prior to the balance sheet date, from
relevant supporting documents.

Information Other than the Financial Statements
and Auditor’s Report Thereon

The Company’s Board of Directors is responsible for the
other information. The other information comprises the
information included in the Board’s report, Management
Discussion and Analysis, Corporate Governance Report
and Business Responsibility and Sustainability Report, but
does not include the consolidated financial statements,
standalone financial statements and our auditor’s report
thereon.

Our opinion on the standalone financial statements does not
cover the other information and we do not express any form
of assurance conclusion thereon.

In connection with our audit of the standalone financial
statements, our responsibility is to read the other information
and, in doing so, consider whether the other information
is materially inconsistent with the standalone financial
statements or our knowledge obtained during the course of
our audit or otherwise appears to be materially misstated.

If, based on the work we have performed, we conclude that
there is a material misstatement of this other information,
we are required to report that fact. We have nothing to report
in this regard.

Responsibilities of Management and Board of
Directors for the Standalone Financial Statements

The Company’s Board of Directors is responsible for the
matters stated in Section 134(5) of the Act with respect to
the preparation of these standalone financial statements
that give a true and fair view of the financial position, financial
performance including other comprehensive income, cash
flows and changes in equity of the Company in accordance
with the accounting principles generally accepted in India,
including Ind AS specified under Section 133 of the Act.
This responsibility also includes maintenance of adequate
accounting records in accordance with the provisions of
the Act for safeguarding the assets of the Company and for
preventing and detecting frauds and other irregularities;
selection and application of appropriate accounting policies;
making judgments and estimates that are reasonable and
prudent; and design, implementation and maintenance of
adequate internal financial controls, that were operating
effectively for ensuring the accuracy and completeness
of the accounting records, relevant to the preparation and
presentation of the financial statements that give a true and
fair view and are free from material misstatement, whether
due to fraud or error.

In preparing the standalone financial statements,
Management and Board of Directors are responsible for
assessing the Company’s ability to continue as a going
concern, disclosing, as applicable, matters related to going
concern and using the going concern basis of accounting
unless the Board of Directors either intend to liquidate
the Company or to cease operations, or has no realistic
alternative but to do so.

The Company’s Board of Directors are also responsible for
overseeing the Company’s financial reporting process.

Auditor’s Responsibility for the Audit of the
Standalone Financial Statements

Our objectives are to obtain reasonable assurance about
whether the standalone financial statements as a whole
are free from material misstatement, whether due to fraud
or error, and to issue an auditor’s report that includes our
opinion. Reasonable assurance is a high level of assurance,
but is not a guarantee that an audit conducted in accordance
with SAs will always detect a material misstatement when it
exists. Misstatements can arise from fraud or error and are
considered material if, individually or in the aggregate, they
could reasonably be expected to influence the economic
decisions of users taken on the basis of these standalone
financial statements.

As part of an audit in accordance with SAs, we exercise
professional judgment and maintain professional skepticism
throughout the audit. We also:

• Identify and assess the risks of material misstatement
of the standalone financial statements, whether due
to fraud or error, design and perform audit procedures
responsive to those risks, and obtain audit evidence
that is sufficient and appropriate to provide a basis
for our opinion. The risk of not detecting a material
misstatement resulting from fraud is higher than for
one resulting from error, as fraud may involve collusion,
forgery, intentional omissions, misrepresentations, or
the override of internal control.

• Obtain an understanding of internal financial controls
relevant to the audit in order to design audit procedures
that are appropriate in the circumstances. Under
Section 143(3)(i) of the Act, we are also responsible
for expressing our opinion on whether the Company
has adequate internal financial controls with reference
to standalone financial statements in place and the
operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies
used and the reasonableness of accounting estimates
and related disclosures made by the Management.

• Conclude on the appropriateness of Management’s use
of the going concern basis of accounting and, based
on the audit evidence obtained, whether a material
uncertainty exists related to events or conditions
that may cast significant doubt on the Company’s
ability to continue as a going concern. If we conclude
that a material uncertainty exists, we are required to
draw attention in our auditor’s report to the related
disclosures in the standalone financial statements
or, if such disclosures are inadequate, to modify
our opinion. Our conclusions are based on the audit
evidence obtained up to the date of our auditor’s report.
However, future events or conditions may cause the
Company to cease to continue as a going concern.

• Evaluate the overall presentation, structure and content
of the standalone financial statements, including the
disclosures, and whether the standalone financial
statements represent the underlying transactions and
events in a manner that achieves fair presentation.

Materiality is the magnitude of misstatements in the
standalone financial statements that, individually or in
aggregate, makes it probable that the economic decisions of
a reasonably knowledgeable user of the standalone financial
statements may be influenced. We consider quantitative
materiality and qualitative factors in (i) planning the scope
of our audit work and in evaluating the results of our work;
and (ii) to evaluate the effect of any identified misstatements
in the standalone financial statements.

We communicate with those charged with governance
regarding, among other matters, the planned scope and
timing of the audit and significant audit findings, including
any significant deficiencies in internal financial controls that
we identify during our audit.

We also provide those charged with governance with a
statement that we have complied with relevant ethical
requirements regarding independence, and to communicate
with them all relationships and other matters that may
reasonably be thought to bear on our independence, and
where applicable, related safeguards.

From the matters communicated with those charged with
governance, we determine those matters that were of
most significance in the audit of the standalone financial
statements of the current year and are therefore the key
audit matters. We describe these matters in our auditor’s
report unless law or regulation precludes public disclosure
about the matter or when, in extremely rare circumstances,
we determine that a matter should not be communicated
in our report because the adverse consequences of doing
so would reasonably be expected to outweigh the public
interest benefits of such communication.

Report on Other Legal and Regulatory Requirements

1. As required by Section 143(3) of the Act, based on our
audit we report, that:

a) We have sought and obtained all the information
and explanations which to the best of our
knowledge and belief were necessary for the
purposes of our audit.

b) In our opinion, proper books of account as required
by law have been kept by the Company so far as
it appears from our examination of those books
except for not complying with the requirement of
audit trail as stated in (i)(vi) below.

c) The Balance Sheet, the Statement of Profit and
Loss including Other Comprehensive Income,
the Statement of Cash Flows and Statement of
Changes in Equity dealt with by this Report are in
agreement with the relevant books of account.

d) In our opinion, the aforesaid standalone financial
statements comply with the Ind AS specified
under Section 133 of the Act.

e) On the basis of the written representations
received from the directors as on 31 March 2026
taken on record by the Board of Directors, none of
the directors is disqualified as on 31 March 2026
from being appointed as a director in terms of
Section 164(2) of the Act.

f) The modification relating to the maintenance of
accounts and other matters connected therewith,
is as stated in paragraph (b) above.

g) With respect to the adequacy of the internal
financial controls with reference to standalone
financial statements of the Company and the
operating effectiveness of such controls, refer to
our separate Report in “Annexure A”. Our report
expresses an unmodified opinion on the adequacy
and operating effectiveness of the Company’s
internal financial controls with reference to
standalone financial statements.

h) With respect to the other matters to be included
in the Auditor’s Report in accordance with the
requirements of Section 197(16) of the Act, as
amended, in our opinion and to the best of our
information and according to the explanations
given to us, the remuneration paid/provided
by the Company to its directors during the year
is in accordance with the provisions of Section
197 of the Act except for the matter stated in
note 33A to the standalone financial statements,
wherein certain amounts towards commission to
independent directors has been provided for, and
are subject to approval of the Shareholders in the
ensuing Annual general meeting.

i) With respect to the other matters to be included
in the Auditor’s Report in accordance with Rule
11 of the Companies (Audit and Auditors) Rules,
2014, as amended in our opinion and to the best of
our information and according to the explanations
given to us:

i. The Company has disclosed the impact of
pending litigations on its financial position
in its standalone financial statements -
Refer note 29 to the standalone financial
statements;

ii. The Company did not have any long-term
contracts including derivative contracts for
which there were any material foreseeable
losses.

iii. There were no amounts which were required
to be transferred to the Investor Education
and Protection Fund by the Company.

iv. (a) The Management has represented
that, to the best of its knowledge and
belief, as disclosed in the note 37(h) to
the standalone financial statements no
funds have been advanced or loaned or
invested (either from borrowed funds or
share premium or any other sources or
kind of funds) by the Company to or in any
other person(s) or entity(ies), including
foreign entities (“Intermediaries”), with
the understanding, whether recorded
in writing or otherwise, that the
Intermediary shall, directly or indirectly
lend or invest in other persons or entities
identified in any manner whatsoever
by or on behalf of the Company
(“Ultimate Beneficiaries”) or provide any
guarantee, security or the like on behalf
of the Ultimate Beneficiaries.

(b) The Management has represented,
that, to the best of its knowledge and
belief, as disclosed in the note 37(i) to
the standalone financial statements,
no funds have been received by
the Company from any person(s)
or entity(ies), including foreign
entities (“Funding Parties”), with the
understanding, whether recorded in
writing or otherwise, that the Company
shall, directly or indirectly, lend or
invest in other persons or entities
identified in any manner whatsoever
by or on behalf of the Funding Party
(“Ultimate Beneficiaries”) or provide any
guarantee, security or the like on behalf
of the Ultimate Beneficiaries.

(c) Based on the audit procedures
performed that have been considered
reasonable and appropriate in the
circumstances, nothing has come to our
notice that has caused us to believe that
the representations under sub-clause (i)

and (ii) of Rule 11(e), as provided under
(a) and (b) above, contain any material
misstatement.

v. The Company has not declared or paid
any dividend during the year and has not
proposed final dividend for the year.

vi. Based on our examination, which included
test checks, the Company has used
accounting softwares for maintaining its
books of account for the year ended 31
March 2026 which has a feature of recording
audit trail (edit log) facility and the same has
operated throughout the year for all relevant
transactions recorded in the softwares except
that in respect of one accounting software,
audit trail was not enabled for certain critical
tables (refer note 41 to the standalone
financial statements). Accordingly, we are
unable to comment on whether there was
any instance of the audit trail feature being
tampered with.

Additionally, the audit trail that was enabled
and operated has been preserved by the
Company as per the statutory requirements
for record retention, as stated in note 41 to
the standalone financial statements.

2. As required by the Companies (Auditor’s Report) Order,
2020 (“the Order”) issued by the Central Government
in terms of Section 143(11) of the Act, we give in
“Annexure B” a statement on the matters specified in
paragraphs 3 and 4 of the Order.

For Deloitte Haskins & Sells

Chartered Accountants
(Firm’s Registration No. 008072S)

Sandeep Kukreja

(Partner)

Place: Bengaluru Membership Number: 220411
Date: 13 May 2026 (UDIN: 26220411KHDZBR6792)


 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Stocks A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others
MUTUAL FUND A B C D E F G H I J K L M N O P Q R S T U V W X Y Z OTHERS
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | MCX | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting | SMART ODR | ODR CIRCULAR
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by